CELU Earnings — Celularity Inc. Class A Common Stock Post-ER Performance | BigEarnings
CELU — Celularity Inc. Class A Common Stock
XNAS
Price$1.07
Market Cap$29.2M
P/E—
52W Range$0.71 – $4.35
Next Earnings2026-08-28
About Celularity Inc. Class A Common Stock
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
